176 related articles for article (PubMed ID: 6614239)
1. Platelet MAO activity and the dexamethasone suppression test in depressed patients.
Schatzberg AF; Orsulak PJ; Rothschild AJ; Salomon MS; Lerbinger J; Kizuka PP; Cole JO; Schildkraut JJ
Am J Psychiatry; 1983 Sep; 140(9):1231-3. PubMed ID: 6614239
[TBL] [Abstract][Full Text] [Related]
2. Platelet MAO activity and the cortisol response to dexamethasone in major depression.
Meltzer HY; Lowy MT; Locascio JJ
Biol Psychiatry; 1988 Jun; 24(2):129-42. PubMed ID: 3390495
[TBL] [Abstract][Full Text] [Related]
3. Toward a biochemical classification of depressive disorders IX. DST results and platelet MAO activity.
Schatzberg AF; Rothschild AJ; Gerson B; Lerbinger JE; Schildkraut JJ
Br J Psychiatry; 1985 Jun; 146():633-7. PubMed ID: 4016477
[TBL] [Abstract][Full Text] [Related]
4. Platelet MAO activity, TRH test, and dexamethasone suppression test in depressed patients.
Loosen PT; Marciniak R
Pharmacopsychiatry; 1988 May; 21(3):131-5. PubMed ID: 3136464
[TBL] [Abstract][Full Text] [Related]
5. Platelet MAO activity and the dexamethasone suppression test in bipolar depression.
Bagdy G; Rihmer Z; Frecska E; Szádóczky E; Arató M
Psychoneuroendocrinology; 1986; 11(1):117-20. PubMed ID: 3704065
[TBL] [Abstract][Full Text] [Related]
6. Psychotic and nonpsychotic depressions: II. Platelet MAO activity, plasma catecholamines, cortisol, and specific symptoms.
Schatzberg AF; Rothschild AJ; Langlais PJ; Lerbinger JE; Schildkraut JJ; Cole JO
Psychiatry Res; 1987 Feb; 20(2):155-64. PubMed ID: 3575560
[TBL] [Abstract][Full Text] [Related]
7. The dexamethasone suppression test (DST) and platelet monoamine oxidase (MAO) activity as predictors of psychosis in depression.
Bloomingdale KL; Vasile RG; Gudeman JE; Gerson B; Schildkraut JJ
Biol Psychiatry; 1986 Apr; 21(4):390-3. PubMed ID: 3955113
[No Abstract] [Full Text] [Related]
8. Monoamine oxidase and cortisol response in depression and schizophrenia.
Pandey GN; Sharma RP; Janicak PG; Davis JM
Psychiatry Res; 1992 Oct; 44(1):1-8. PubMed ID: 1461943
[TBL] [Abstract][Full Text] [Related]
9. Classification of patients with affective disorders using platelet monoamine oxidase activity, serum melatonin and post-dexamethasone cortisol.
Wahlund B; Sääf J; Wetterberg L
Acta Psychiatr Scand; 1995 May; 91(5):313-21. PubMed ID: 7639087
[TBL] [Abstract][Full Text] [Related]
10. Relationship of platelet MAO activity to characteristics of major depressive illness.
Georgotas A; McCue RE; Friedman E; Hapworth WE; Kim OM; Cooper TB; Chang I; Stokes PE
Psychiatry Res; 1986 Dec; 19(4):247-56. PubMed ID: 3809323
[TBL] [Abstract][Full Text] [Related]
11. Plasma cortisol, catecholamine and cyclic AMP levels, response to dexamethasone suppression test and platelet MAO activity in manic-depressive patients. A longitudinal study.
Maj M; Ariano MG; Arena F; Kemali D
Neuropsychobiology; 1984; 11(3):168-73. PubMed ID: 6089030
[TBL] [Abstract][Full Text] [Related]
12. [DST urinary MHPG.SO4 excretion and platelet MAO activity in depression].
Zhou DF
Zhonghua Shen Jing Jing Shen Ke Za Zhi; 1985 Oct; 18(5):274-8. PubMed ID: 3833511
[No Abstract] [Full Text] [Related]
13. [Platelet monoamine oxidase and sex hormones in a population of depressed patients].
Poirier MF; Lôo H; Lefur G; Mitrani N
Encephale; 1985; 11(3):125-9. PubMed ID: 4029076
[TBL] [Abstract][Full Text] [Related]
14. Platelet MAO activity in clinical subtypes of depression and DST suppression.
Poirier MF; Lôo H; Mitrani N; Benkelfat C; Askienazy S; Le Fur G
Acta Psychiatr Scand; 1987 May; 75(5):456-63. PubMed ID: 3604729
[TBL] [Abstract][Full Text] [Related]
15. Platelet MAO activity and age at onset of depression in elderly depressed women.
Alexopoulos GS; Lieberman KW; Young RC; Shamoian CA
Am J Psychiatry; 1984 Oct; 141(10):1276-8. PubMed ID: 6486267
[TBL] [Abstract][Full Text] [Related]
16. Primary early onset dysthymia, biochemical correlates of the therapeutic response to fluoxetine: I. Platelet monoamine oxidase and the dexamethasone suppression test.
Ravindran AV; Bialik RJ; Lapierre YD
J Affect Disord; 1994 Jun; 31(2):111-7. PubMed ID: 8071473
[TBL] [Abstract][Full Text] [Related]
17. Toward a biochemical classification of depressive disorders, VI: Platelet MAO activity and clinical symptoms in depressed patients.
Gudeman JE; Schatzberg AF; Samson JA; Orsulak PJ; Cole JO; Schildkraut JJ
Am J Psychiatry; 1982 May; 139(5):630-3. PubMed ID: 7072851
[TBL] [Abstract][Full Text] [Related]
18. Platelet MAO activity in anorexia nervosa patients with and without a major depressive disorder.
Biederman J; Rivinus TM; Herzog DB; Ferber RA; Harper GP; Orsulak PJ; Harmatz JS; Schildkraut JJ
Am J Psychiatry; 1984 Oct; 141(10):1244-7. PubMed ID: 6486260
[TBL] [Abstract][Full Text] [Related]
19. Prediction of response to nortriptyline and phenelzine by platelet MAO activity.
Georgotas A; McCue RE; Friedman E; Cooper T
Am J Psychiatry; 1987 Mar; 144(3):338-40. PubMed ID: 3826434
[TBL] [Abstract][Full Text] [Related]
20. Low platelet MAO activity in psychiatric patients and plasma factors: no evidence for inhibitory influences on MAO in the circulating platelet population.
Demisch L; Gebhart P; Kaczmarczyk P; von der Mühlen H; Bochnik HJ
Biol Psychiatry; 1981 Jan; 16(1):21-33. PubMed ID: 7225472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
